Company News_Guangzhou Vesber

HOME
ABOUT VESBER
- Profile
- Culture
- History
- R&D
PRODUCTS
BLOG
COOPERATION
- Hospital
- Overseas
RECRUITMENT
CONTACT US
- Information
- Online Message

Language
- English
- 中文
- Deutsch

BLOG

Patient-centered, physician-partner, employee-based

Company News

Product News

Media

First Successful Third-Generation FCVB Surgery Performed at University Hospitals Leuven, Belgium

Oct 11,2024

Vesber has moved into the China-Europe (Duisburg) Innovation Center and will vigorously expand its overseas market!

On the afternoon of September 24, 2024, the China-Europe(Duisburg) Innovation Center, located in Duisburg, Germany, hosted an "Innovative Ophthalmic Technology Cooperation Conference" and a welcoming event for new projects.

Sep 27,2024

Vesber Participates in the 24th Euretina Congress, with FCVB & FCB New Technologies Receiving Praise!

From September 19 to 22, one of the largest professional conferences in the field of retinal disease research and treatment, the 24th Annual Meeting of the European Society of Retina Specialists (EURETINA 2024), concluded successfully in Barcelona, Spain. At this top international annual academic conference, Vesber showcased its innovative products, the Foldable Capsular Vitreous Body (FCVB) and the Foldable Capsular Buckle (FCB), attracting experts from various countries to discuss new technologies for treating eye injuries and retinal detachment, creating a very lively atmosphere on site.

Sep 25,2024

The University Hospital affiliated with the Faculty of Medicine at KU Leuven in Belgium successfully performed the first third-generation FCVB surgery

On September 16th, Dr. Peter Stalmans, MD, PhD, the head of the Department of Ophthalmology at the University Hospital affiliated with the Faculty of Medicine at KU Leuven, Belgium, successfully used the third-generation FCVB for the first time to implant a balloon in a patient with a severely injured eye resulting from a serious eye injury, preserving the atrophied eyeball.

Sep 18,2024

Exhibition Preview! VESBER Participates in Euretina Congress to Showcase Chinese Ophthalmic Innovative Technologies

Sep 13,2024

Vesber Showcases FCVB and FCB at the Beijing Ophthalmology Conference, Innovative Technology Receives Praise

To further implement the national blueprint for building a new development pattern, accelerating the advancement of the Healthy China strategy, and constructing the Health Silk Road, the "2024 Beijing Health Conference," meticulously organized by the International Exchange and Cooperation Center of the National Health Commission, was inaugurated at the Beijing National Convention Center from August 9-11.

Aug 13,2024

< 1...8 9 10...12 >

R&D Center

Media

Cases

Search for product information you are interested in

all

all
product management
News

+8618960050093

Building11,No.6,Nanjiang 2nd Road, Zhujiang Street, Nansha District,Guangzhou

www.vesber.cn

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

License